This Article Full Text Full Text (PDF) CME: Take the course for this article: Circulation: July 31, 2007, Volume 116, Number 5 Data Supplement All Versions of this Article: 116/5/497    most recent CIRCULATIONAHA.107.691972v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lietz, K. Articles by Miller, L. W. Search for Related Content PubMed PubMed Citation Articles by Lietz, K. Articles by Miller, L. W. Pubmed/NCBI databases Medline Plus Health Information Heart Failure Related Collections CV surgery: transplantation, ventricular assistance, cardiomyopathy

(Circulation. 2007;116:497-505.)
© 2007 American Heart Association, Inc.

Heart Failure

Outcomes of Left Ventricular Assist Device Implantation as Destination Therapy in the Post-REMATCH Era

Implications for Patient Selection

Katherine Lietz, MD, PhD; James W. Long, MD, PhD; Abdallah G. Kfoury, MD; Mark S. Slaughter, MD; Marc A. Silver, MD; Carmelo A. Milano, MD; Joseph G. Rogers, MD; Yoshifumi Naka, MD, PhD; Donna Mancini, MD; Leslie W. Miller, MD

From the Cardiovascular and Cardiothoracic Divisions of University of Minnesota, Minneapolis (K.L., L.W.M.); Georgetown University–Washington Hospital Center, Washington, DC (K.L., L.W.M.); LDS Hospital, Salt Late City, Utah (J.W.L., A.G.K.); Advocate Christ Medical Center, Oak Lawn, Ill (M.S.S., M.A.S.); Duke University Medical Center, Durham, NC (C.A.M., J.G.R.); and Columbia-Presbyterian Medical Center, New York, NY (Y.N., D.M.). Dr Lietz is now affiliated with the Division of Cardiology, Columbia-Presbyterian Medical Center, New York, NY.

Correspondence to Katherine Lietz, MD, PhD, Center for Advanced Cardiac Care, Division of Cardiology, Columbia-Presbyterian Medical Center, PH-12 Stem Rm 134, 622 W 168th St, New York, NY 10032. E-mail KL2384{at}columbia.edu

Received January 25, 2007; revision received May 8, 2007.

Background— The landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial first demonstrated that implantation of left ventricular assist devices (LVADs) as destination therapy (DT) can provide survival superior to any known medical treatment in patients with end-stage heart failure who are ineligible for transplantation. In the present study, we describe outcomes of DT in the post-REMATCH era in the United States.

Methods and Results— The present study included 280 patients who underwent HeartMate XVE LVAD implantation between November 2001 and December 2005. A preoperative risk score for in-hospital mortality after LVAD implantation was established in 222 patients with complete data. All patients were followed up until death or December 2006. The 1-year survival after LVAD implantation was 56%. The in-hospital mortality after LVAD surgery was 27%. The main causes of death included sepsis, right heart failure, and multiorgan failure. The most important determinants of in-hospital mortality were poor nutrition, hematological abnormalities, markers of end-organ or right ventricular dysfunction, and lack of inotropic support. Stratification of DT candidates into low (n=65), medium (n=111), high (n=28), and very high (n=18) risk on the basis of the risk score calculated from these predictors corresponded with 1-year survival rates of 81%, 62%, 28%, and 11%, respectively.

Conclusions— Appropriate selection of candidates and timing of LVAD implantation are critical for improved outcomes of DT. Patients with advanced heart failure who are referred for DT before major complications of heart failure develop have the best chance of achieving an excellent 1-year survival with LVAD therapy.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				M. Struber, K. Sander, J. Lahpor, H. Ahn, P.-Y. Litzler, S. G. Drakos, F. Musumeci, C. Schlensak, I. Friedrich, R. Gustafsson, et al. HeartMate II left ventricular assist device; early European experience Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 289 - 294. [Abstract] [Full Text] [PDF]

				R. H. Jones The Year in Cardiovascular Surgery J. Am. Coll. Cardiol., April 29, 2008; 51(17): 1707 - 1718. [Full Text] [PDF]

				L. W. Miller, F. D. Pagani, S. D. Russell, R. John, A. J. Boyle, K. D. Aaronson, J. V. Conte, Y. Naka, D. Mancini, R. M. Delgado, et al. Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation N. Engl. J. Med., August 30, 2007; 357(9): 885 - 896. [Abstract] [Full Text] [PDF]

				S. A. Hunt Mechanical Circulatory Support: New Data, Old Problems Circulation, July 31, 2007; 116(5): 461 - 462. [Full Text] [PDF]